Nishtha Sareen

Nishtha Sareen practices at Ascension Saint Thomas Hospital West in Nashville, Tennessee, part of Ascension Health Alliance.

Nishtha Sareen's NPI, 1154633899, was assigned on July 10, 2010. Nishtha Sareen holds Michigan license 4301100167.

Nishtha Sareen's primary practice is Ascension Saint Thomas Hospital West, at 4220 Harding Rd, PO Box 380, Nashville, TN 37205 in Davidson County. The practice phone is (615) 222-2111.

Nishtha Sareen's primary practice is Ascension Saint Thomas Hospital West in Nashville, Tennessee, part of Ascension Health Alliance. Nishtha Sareen is also affiliated with Williamson Medical Center. The medical group on file is Ascension Saint Thomas Medical Partners. Dmand AI also links Nishtha Sareen to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nishtha Sareen practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Nishtha Sareen's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Nishtha Sareen's licenses on file in 2 states: Michigan and Tennessee.

CMS data shows 1,242 Medicare services from Nishtha Sareen across 23 procedure codes in 2024, for 603 Medicare patients. Medicare paid $57,645 for them.

CMS counts 603 Medicare patients who saw Nishtha Sareen in 2024. The largest group is 65 to 74, with 215 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nishtha Sareen's median patient age at 67, with 76% women.

In 2024, Nishtha Sareen wrote 2,381 Medicare Part D claims for 421 patients. 84% of them were for generic drugs. CMS names the drug for 2,155 of them, across 34 drugs with 11 or more claims each, at $383,845 in total drug cost. In 2023, CMS named 1,691 claims across 29 drugs.

Nishtha Sareen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nishtha Sareen as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Nishtha Sareen, more than 42% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Nishtha Sareen, published from 2012 to 2025. 2025 was the busiest year, with 5. The most frequent topics are Coronary Artery Disease, Percutaneous Coronary Intervention and Acute Coronary Syndrome. Nishtha Sareen has published most often in Methodist Debakey Cardiovasc J. Nishtha Sareen's most frequent co-authors are Yashwant Agrawal, MD, Usman Baber, MD and Nitin Barman, MD.

CMS Open Payments shows 184 general payments to Nishtha Sareen from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Abbott Laboratories paid the most, $8,658.